Are they worth it? Executive compensation, company performance don't always relate at top hospital, post-acute and insurance companies.

Modern Healthcare's first comprehensive report on CEO pay at the top for-profit healthcare providers and insurers shows pay and stock performance aren't always linked. One exception is Norman Payson, left, who was tapped in 1998 to help turn around then-faltering Oxford Health Plans. He pulled in total direct compensation of $76 million last year, including $73 million in exercised stock options.